A review article discussed the expanding role of biologics in treating components of metabolic syndrome, including glucagon-like peptide 1 (GLP-1) analogs for type 2 diabetes and obesity and ...
A new study from the University of North Carolina has helped doctors and patients better understand which medications are ...
Medicare beneficiaries will save on top Part D drugs in 2027, with price cuts up to 85% under the Inflation Reduction Act. Read more here.
The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...
CMS has negotiated a 71% discount off the list price, or $274 for a 30-day supply, on Novo Nordisk’s semaglutide products — Ozempic and Rybelsus for diabetes and Wegovy for weight loss — through the ...
Rutgers scientists found that metformin can blunt many of the metabolic and cardiovascular improvements normally produced by exercise. Participants who took the drug saw reduced gains in fitness, ...
Metformin (1,1-dimethylbiguanide hydrochloride), is today, the most prescribed oral medicine for type 2 diabetes, taken by millions of people every day. It is inexpensive, effective, and widely ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. SITAGLIPTIN/METFORMIN XR MYLAN contains the active ingredients ...
Metformin is an unassuming hero of modern medicine. For more than 60 years, this humble pill has been a mainstay of diabetes care, helping millions of people manage their blood sugar. It lowers blood ...
The oral solution is supplied in a 120 mL bottle containing 25 mg of sitagliptin per mL. Brynovin ™, an oral solution formulation of sitagliptin, is now available from Azurity Pharmaceuticals.
WOBURN, Mass., July 31, 2025 /PRNewswire/ -- Azurity Pharmaceuticals, Inc. announced today the availability of BRYNOVIN™ (sitagliptin) oral solution, a dipeptidyl peptidase-4 (DPP-4) inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results